TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia

Defects in the tumor suppressor gene TP53 are known to be important in chronic lymphocytic leukemia (CLL) and TP53 inactivation is associated with a particularly aggressive form of the disease. The single nucleotide polymorphism in the TP53 gene at codon 72 (rs1042522), results in amino acid substit...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2014
Main Authors: Bilous, N.I., Abramenko, I.V., Chumak, A.A., Dyagil, I.S., Martina, Z.V.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2014
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/145384
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia / N.I. Bilous, I.V. Abramenko, A.A. Chumak, I.S. Dyagil, Z.V. Martina // Experimental Oncology. — 2014. — Т. 36, № 4. — С. 258-261. — Бібліогр.: 30 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862729193039593472
author Bilous, N.I.
Abramenko, I.V.
Chumak, A.A.
Dyagil, I.S.
Martina, Z.V.
author_facet Bilous, N.I.
Abramenko, I.V.
Chumak, A.A.
Dyagil, I.S.
Martina, Z.V.
citation_txt TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia / N.I. Bilous, I.V. Abramenko, A.A. Chumak, I.S. Dyagil, Z.V. Martina // Experimental Oncology. — 2014. — Т. 36, № 4. — С. 258-261. — Бібліогр.: 30 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Defects in the tumor suppressor gene TP53 are known to be important in chronic lymphocytic leukemia (CLL) and TP53 inactivation is associated with a particularly aggressive form of the disease. The single nucleotide polymorphism in the TP53 gene at codon 72 (rs1042522), results in amino acid substitution influencing apoptotic potential of TP53 protein. The aim of the study was to evaluate the association of the TP53 codon 72 polymorphism and incidence of TP53 mutations in CLL patients. Methods: 261 CLL samples were analyzed by polymerase chain reaction and direct sequencing for TP53 mutations and single nucleotide polymorphism. Results: The 72Pro/Pro genotype was associated with an increased incidence of TP53 mutations in previously treated patients (OR = 2.503; 95% CI 1.142–5.487; р = 0.001). Conclusion: This study revealed that the TP53 codon 72 polymorphism may be used as a risk factor for incidence of TP53 mutations in CLL. Key Words: chronic lymphocytic leukemia, TP53 mutations, single nucleotide polymorphism.
first_indexed 2025-12-07T19:13:39Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-145384
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-12-07T19:13:39Z
publishDate 2014
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Bilous, N.I.
Abramenko, I.V.
Chumak, A.A.
Dyagil, I.S.
Martina, Z.V.
2019-01-21T11:34:56Z
2019-01-21T11:34:56Z
2014
TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia / N.I. Bilous, I.V. Abramenko, A.A. Chumak, I.S. Dyagil, Z.V. Martina // Experimental Oncology. — 2014. — Т. 36, № 4. — С. 258-261. — Бібліогр.: 30 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/145384
Defects in the tumor suppressor gene TP53 are known to be important in chronic lymphocytic leukemia (CLL) and TP53 inactivation is associated with a particularly aggressive form of the disease. The single nucleotide polymorphism in the TP53 gene at codon 72 (rs1042522), results in amino acid substitution influencing apoptotic potential of TP53 protein. The aim of the study was to evaluate the association of the TP53 codon 72 polymorphism and incidence of TP53 mutations in CLL patients. Methods: 261 CLL samples were analyzed by polymerase chain reaction and direct sequencing for TP53 mutations and single nucleotide polymorphism. Results: The 72Pro/Pro genotype was associated with an increased incidence of TP53 mutations in previously treated patients (OR = 2.503; 95% CI 1.142–5.487; р = 0.001). Conclusion: This study revealed that the TP53 codon 72 polymorphism may be used as a risk factor for incidence of TP53 mutations in CLL. Key Words: chronic lymphocytic leukemia, TP53 mutations, single nucleotide polymorphism.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
Article
published earlier
spellingShingle TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
Bilous, N.I.
Abramenko, I.V.
Chumak, A.A.
Dyagil, I.S.
Martina, Z.V.
Original contributions
title TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
title_full TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
title_fullStr TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
title_full_unstemmed TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
title_short TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
title_sort tp53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia
topic Original contributions
topic_facet Original contributions
url https://nasplib.isofts.kiev.ua/handle/123456789/145384
work_keys_str_mv AT bilousni tp53codon72singlenucleotidepolymorphisminchroniclymphocyticleukemia
AT abramenkoiv tp53codon72singlenucleotidepolymorphisminchroniclymphocyticleukemia
AT chumakaa tp53codon72singlenucleotidepolymorphisminchroniclymphocyticleukemia
AT dyagilis tp53codon72singlenucleotidepolymorphisminchroniclymphocyticleukemia
AT martinazv tp53codon72singlenucleotidepolymorphisminchroniclymphocyticleukemia